Drugs for COVID-19
CURRENT
ISSUE
1686

Two recombinant vaccines, Arexvy (GSK) and Abrysvo (Pfizer), have been approved by the FDA for prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV) in adults ≥60 years old. They are the first RSV vaccines to be approved in the US. Abrysvo is also approved for use in pregnant women at 32-36 weeks' gestation to prevent LRTD caused by RSV in their infants from birth through 6 months of age.

RSV DISEASE ― RSV typically causes a mild upper respiratory tract infection, but infants <6 months old and older adults, particularly those with...  Continue reading

Coming Soon
Drugs for Gout
Shockwave Therapy for Erectile Dysfunction
Antiviral Drugs for Influenza for 2023-2024
AD-Detect – A Blood Test for Alzheimer’s Disease